home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Stability Testing in Pharmaceutical Development and Manufacturing (2 day)

 
  February 21, 2011  
     
 
PharmaTraining Limited, Window Conference Venue, 13 Windsor Street, Islington, London, N1 8QG, United Kingdom
2011-12-12


Course objectives
New and important techniques in stability testing are facilitating product development using the Quality by Design approach. Using these it is possible to develop products more quickly and reliably, through improved methods of shelf life prediction and excipient testing. New stability testing protocols using the published ASAP method from Pfizer can generate information quickly and reliably. The purpose of this course is to give a comprehensive, integrated overview of pharmaceutical stability testing in a highly interactive, relaxed environment:
Why is stability testing required for product registration and GMP purposes?
What are the requirements for Clinical Trials, new, and existing products?
How can stability testing be applied during product development to shorten development times as well as improve product quality
Stability testing outsourcing - successful management and execution

It will include:
A comprehensive review of ICH stability testing guidance ICH Q1A
Pitfalls in stability testing. Outsourcing—costs and benefits
New approaches to stability testing including ASAP and the role of peroxides in product stability
Stability Testing and QbD
Workshops for attendees to present and discuss their own stability testing issues with the group

Who will benefit:
The course is designed for people working in:
Analytical and Product Development. Analytical Chemistry. Stability Testing. Formulation Development. Regulatory Affairs. Pharmaceutical & Biopharmaceutical Production. Quality Control and Quality Assurance. Technical Operations

Course Programme

Day 1
Introductions
The life cycle approach to product development and Quality by Design. Stability testing in product development
Lunch
ICH Guidance Q1A (R2) – a comprehensive review. Case study “Effect of Processing and Formulation Variables on the stability of a salt of a weakly basic drug candidate (tablet)” – Badawy et al, BMS. EU GMP guidance on stability testing.

Day 2
ICH Q6 – specifications, and how to set them. Role of specifications in stability testing. Alternative approaches to deriving specifications. Evaluation of stability data – ICH guidance Q1E. Identifying out of trend data. Alternative approaches. Data interpretation case studies including attendee problems
Lunch
Bracketing and matrixing designs for stability testing of new drug substances and products - ISC Q1E. Photostability testing—Q1B. Action Planning and Final Q&A.

Workshop and examples based on delegate’s interests.
Group discussion, problem solving and consultancy

Additional Resources
Online access to comprehensive publications including all relevant guidance will be provided as well as colour copies of all presentations and case studies.

 
 
Organized by: PharmaTraining Limited
Invited Speakers: Dr Michael Gamlen is Managing Director of Pharmaceutical Development Services Ltd, a pharmaceutical consultancy based in Nottingham (UK). Dr Gamlen has over 30 years experience of tablet development. Awarded a First Class Honours degree in Pharmacy, specialising in Pharmaceutical Engineering, he studied for a PhD at Nottingham University. He was Head of Tablet Development at the The Wellcome Foundation for 15 years, and worked as an outsourcing manager before starting his consultancy business in 2000.
 
Deadline for Abstracts: .
 
Registration:

http://pharma-training-courses.com/stability-testing-in-pharmaceutical-development-and-manufacturing.html

E-mail: judy@pharma-training-courses.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.